![Medtronic PROTECTA XT DR D314DRG Скачать руководство пользователя страница 41](http://html.mh-extra.com/html/medtronic/protecta-xt-dr-d314drg/protecta-xt-dr-d314drg_clinician-manual_1763148041.webp)
3 Clinical data
3.1 Adverse events and clinical trial data
Information regarding clinical studies and adverse events related to this device is available
at www.medtronic.com/manuals. To view, download, print, or order the following clinical
studies from the Medtronic website, perform the following steps:
1. Navigate your web browser to http://www.medtronic.com/manuals.
2. Select the hyperlink that corresponds to your location.
3. Select the Search field on the left side of the screen and type “D314DRG”.
4. Click [Search]. All technical literature for this device is listed.
The following clinical studies are related to this device:
Atrial Capture Management (ACM) study – This clinical study, which evaluated the Atrial
Capture Management feature in EnPulse pacemakers, provides support for the Atrial
Capture Management feature in Protecta XT DR Model D314DRG devices.
Atrial Fibrillation Symptoms Mediated by Pacing to Mean Rates (AF SYMPTOMS) –
This study evaluated the long-term effects of Conducted AF Response in patients with atrial
fibrillation and intact atrioventricular (AV) conduction. It provides support for the Conducted
AF Response feature in Protecta XT DR Model D314DRG devices. Note that the Ventricular
Response Pacing (VRP) feature mentioned in the study is called Conducted AF Response
in the Protecta XT DR Model D314DRG devices.
Atrial Septal Pacing Efficacy Trial (ASPECT) – This clinical study, which evaluated the
safety and efficacy of the Medtronic AT500 DDDRP Pacing System devices, provides
support for the atrial intervention pacing therapies.
Atrial Therapy Efficacy and Safety Trial (ATTEST) – This clinical study, which evaluated
the safety and efficacy of the Medtronic AT500 DDDRP Pacing System devices, provides
support for the Protecta XT DR Model D314DRG devices.
The Enhanced Surveillance of Right Ventricle Lead Integrity Alert (RV LIA) – This
study, which prospectively assessed the performance of the Right Ventricle Lead Integrity
Alert, provided an estimate of the probability of receiving a three-day warning for patients
with a lead fracture. The study provides support for the RV Lead Integrity Alert feature in
Protecta XT DR Model D314DRG devices.
EnRhythm clinical study – This clinical study, which evaluated the safety and efficacy of
the EnRhythm Model P1501DR devices, provides support for MVP mode pacing and the
Reactive ATP feature in the Protecta XT DR Model D314DRG devices.
Medtronic
PROTECTA™ XT DR D314DRG
Clinician Manual
41
Содержание PROTECTA XT DR D314DRG
Страница 2: ......
Страница 9: ...Index 488 Medtronic PROTECTA XT DR D314DRG Clinician Manual 9 ...
Страница 506: ......
Страница 507: ......